These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8412405)

  • 1. [Clinical epidemiology of an outbreak of nosocomial infections by Staphylococcus aureus resistant to methicillin and aminoglucosides: efficacy of the measures of control].
    Parras F; Coello R
    Med Clin (Barc); 1993 Sep; 101(9):359. PubMed ID: 8412405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical epidemiology of an outbreak of nosocomial infection caused by Staphylococcus aureus resistant to methicillin and aminoglycosides: efficacy of control measures. Comité de Control de Infecciones].
    Trilla A; Marco F; Moreno A; Prat A; Soriano E; Jiménez de Anta MT
    Med Clin (Barc); 1993 Feb; 100(6):205-9. PubMed ID: 8429724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin resistant Staphylococcus aureus: where are we now?
    Allen DM
    Singapore Med J; 1991 Feb; 32(1):17-9. PubMed ID: 2017696
    [No Abstract]   [Full Text] [Related]  

  • 4. [The reduction of methicillin resistance in Streptococcus aureus in a hospital environment in Sousse (Tunisia)].
    Mzoughi R; Gouiaa R; Jeddi M
    Bull Soc Pathol Exot; 1994; 87(2):89-90. PubMed ID: 8061534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
    Safdar N; Marx J; Meyer NA; Maki DG
    Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

  • 8. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What is certain in the topical eradication of MRSA from carriers?].
    Dziekan G; Mlangeni D; Daschner FD
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):761-3. PubMed ID: 11455670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mitral endocarditis caused by Staphylococcus aureus resistant to methicillin, aminoglucosides and rifampicin: description of 2 cases with fatal course].
    Serrano R; Miró JM; Marco F; Cartañá R; Muñoz J; Sacanellas E; Trilla A; Soriano E
    Med Clin (Barc); 1993 Oct; 101(10):379-82. PubMed ID: 8231345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Kanno H
    Nihon Rinsho; 1990 Oct; 48(10):2355-64. PubMed ID: 2177799
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 14. A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
    Cunha BA
    J Hosp Infect; 2008 Mar; 68(3):271-3. PubMed ID: 18289722
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methicillin-resistant Staphylococcus aureus nosocomial infections: epidemiology, prevention and antibiotic therapy].
    Libert J
    Ann Pharm Fr; 2000 May; 58(3):153-6. PubMed ID: 10844274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [As carefully as in fire hazard. How to stop the methicillin resistant staphylococcus].
    Tammelin A
    Lakartidningen; 2001 Nov; 98(47):5302-5. PubMed ID: 11763626
    [No Abstract]   [Full Text] [Related]  

  • 17. What you need to know about ... Methicillin resistant Staphylococcus aureus (MRSA).
    Nurs Times; 2003 Mar 4-10; 99(9):28. PubMed ID: 12673983
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of healthcare-associated methicillin-resistant Staphylococcus aureus.
    Hsu LY; Wijaya L; Tan BH
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):893-905. PubMed ID: 16307502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin resistant Staphylococcus aureus infections-implications in hospital infection control.
    Krishna BV; Patil A; Chandrasekhar MR
    Indian J Public Health; 2007; 51(1):43-6. PubMed ID: 18232141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we control the spread of antibiotic-resistant nosocomial pathogens? The methicillin-resistant Staphylococcus aureus paradigm.
    Struelens MJ; Denis O
    Curr Opin Infect Dis; 2006 Aug; 19(4):321-2. PubMed ID: 16804377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.